We have reiterated our Neutral recommendation on AmSurg Corporation (AMSG) with a target price of $31.00.
Even amid headwinds like reimbursement issues, higher expenses and...(read more
AmSurg Corp.'s (AMSG) second quarter EPS of $0.38 met the Zacks Consensus Estimate and the year-ago EPS. Economic uncertainty has been impacting AmSurg potential customers deferring...(read more
Hilliard Lyons is Neutral on AmSurg Corporation (NASDAQ: AMSG) in a research report released today.
In a note to clients, Hilliard Lyons writes, "There was little change in AmSurg's operating environment in the third quarter. As in...(read more